2017-2018 Influenza season kicks off

The American College of Obstetricians and Gynecologists (ACOG) on October 25, 2017 published an “Immunization Newsletter,” pointing out that this year’s Influenza season has started, and that ACOG and quite a number of other professional organizations encourage physicians to administer Influenza vaccine to all pregnant patients (the recommendation also encompasses all women attempting to conceive).

In 2016-17, according to this announcement, only 53.6% of women received a flu vaccine before or during pregnancy, only slightly up from the season before where the rate had been 49.9%.

Influenza vaccination is recommended in pregnancy because this viral infection in pregnant women manifests often more severely, which can have adverse consequences for mothers and offspring. CHR, therefore, also strongly encourages immunization!

CHR, as readers may recall from last year’s flu season, is also conducting a clinical trial under the hypothesis that Influenza vaccinations may have beneficial effects on implantation and miscarriage rates in IVF. The prestigious journal, SCIENCE, in 2016 picked up the story of this trial for a full-length article. Participants in this trial will get the Influenza vaccination for free. Please let the CHR staff known if you are interested in participating in the trial!

This is a part of the November 2017 CHR VOICE.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.